Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ardent Health, Inc.ARDT · Entity 4664 | Director · President and CEO | March 31, 2026 | April 02, 2026 |
| COMMUNITY HEALTH SYSTEMS INCCYH · Entity 5628 | Division President | March 01, 2017 | March 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ardent Health, Inc.
Report date March 31, 2026 · Filed April 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,437,937 |
Ending reported balance
After 2026-04-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-31 · Tax withholding · Disposed 8,026 · Balance 1,314,274 F1: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2: Represents the closing price of the common stock of the Issuer on March 31, 2026. Row 2 · 2026-04-01 · Tax withholding · Disposed 10,952 · Balance 1,303,322 F1: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3: Represents the closing price of the common stock of the Issuer on April 1, 2026. Row 3 · 2026-04-01 · Grant · Acquired 134,615 · Balance 1,437,937 F4: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
F2: Represents the closing price of the common stock of the Issuer on March 31, 2026.
F3: Represents the closing price of the common stock of the Issuer on April 1, 2026.
F4: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date
COMMUNITY HEALTH SYSTEMS INC
Report date March 01, 2017 · Filed March 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 100,458 |
Ending reported balance
After 2017-03-01 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2017-03-01 · Grant · Acquired 20,000 · Balance 80,143 F1: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Row 2 · 2017-03-01 · Exercise / conversion · Acquired 35,000 · Balance 115,143 Row 3 · 2017-03-01 · Tax withholding · Disposed 14,685 · Balance 100,458 |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-02-28 | Direct | 0 |
Reported balance
After 2017-03-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-03-01 · Exercise / conversion · Disposed 35,000 · Balance 0 F2: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant. |
| Performance Based RestrictedSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-28 | Direct | 20,000 |
Reported balance
After 2017-03-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-03-01 · Grant · Acquired 20,000 · Balance 20,000 F3: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.49 · Expires 2021-12-13 | Direct | 1,000 |
Reported balance
Holding disclosure · report date 2017-03-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 1,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F2: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant.
F3: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2026 Filed Apr 2, 2026 20:24 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 134,615 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-023203 · wk-form4_1775161490.xml · nonDerivative · entry 3 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,437,937 F4 · shares: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date Read SEC document |
| April 01, 2026 Filed Apr 2, 2026 20:24 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 10,952 | $8.67 | $94,953.84 |
DisclosureSEC source: 0001628280-26-023203 · wk-form4_1775161490.xml · nonDerivative · entry 2 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,303,322 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F3 · price: Represents the closing price of the common stock of the Issuer on April 1, 2026. Read SEC document |
| March 31, 2026 Filed Apr 2, 2026 20:24 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 8,026 | $8.56 | $68,702.56 |
DisclosureSEC source: 0001628280-26-023203 · wk-form4_1775161490.xml · nonDerivative · entry 1 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,314,274 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on March 31, 2026. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 20:17 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 195,316 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-017714 · wk-form4_1773433039.xml · nonDerivative · entry 1 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,322,300 F1 · shares: Shares earned based on 2024 and 2025 performance under performance vesting restricted stock units awarded on July 18, 2024. Pursuant to the terms of the award, the shares will vest on December 31, 2026 contingent upon service through such date. Read SEC document |
| April 01, 2025 Filed Apr 2, 2025 21:11 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 134,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-016263 · wk-form4_1743628309.xml · nonDerivative · entry 2 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,126,984 F3 · shares: Represents restricted stock units that vest in three substantially equal installments on each anniversary of April 1, 2025, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 21:11 UTC | Ardent Health, Inc. ARDT · Entity 4664 | Tax withholdingCommon Stock | 12,970 | $13.75 | $178,337.50 |
DisclosureSEC source: 0001628280-25-016263 · wk-form4_1743628309.xml · nonDerivative · entry 1 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 992,057 F1 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. F2 · price: Represents the closing price of the common stock of the Issuer on March 31, 2025. Read SEC document |
| July 18, 2024 Filed Jul 22, 2024 21:49 UTC | Ardent Health, Inc. ARDT · Entity 4664 | GrantCommon Stock | 98,881 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001950 · form4.xml · nonDerivative · entry 1 Bonick Martin · CIK 0001598595 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,005,027 F1 · shares: Represents restricted stock units that vest in 3 substantially equal installments on each anniversary of March 31, 2024, subject to the Reporting Person's continued service with the Issuer through each applicable vesting date. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:10 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantPerformance Based Restricted · Derivative | 20,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016527 · doc4.xml · derivative · entry 5 Bonick Martin · CIK 0001598595 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-02-28 F3 · derivative.exercise_date: The vesting of 80% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Same-Store Adjusted EBITDA Growth between January 1, 2017 and December 31, 2019 (the "Performance Period"). The vesting of the remaining 20% of these performance-based restricted shares is subject to the attainment of a pre-determined level of Cumulative Adjusted EPS for the Performance Period. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the Cumulative Same-Store Adjusted EBITDA Growth and Cumulative Adjusted EPS criteria, as applicable, will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the Performance Period. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:10 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionPerformance Based Restricted · Derivative | 35,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016527 · doc4.xml · derivative · entry 4 Bonick Martin · CIK 0001598595 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The performance objectives governing these shares of Performance Based Restricted Stock have been met, and, accordingly, these shares will now be reported in Table 1 as directly owned shares of Restricted Stock. The time-vesting restrictions lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:10 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Tax withholdingCommon Stock | 14,685 | $9.19 | $134,955.15 |
DisclosureSEC source: 0001209191-17-016527 · doc4.xml · nonDerivative · entry 3 Bonick Martin · CIK 0001598595 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,458 Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:10 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | Exercise / conversionCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016527 · doc4.xml · nonDerivative · entry 2 Bonick Martin · CIK 0001598595 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 2, 2017 21:10 UTC | COMMUNITY HEALTH SYSTEMS INC CYH · Entity 5628 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-016527 · doc4.xml · nonDerivative · entry 1 Bonick Martin · CIK 0001598595 · Division President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,143 F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.